Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-37.20	54.46	86.73
Graham Fair Price	8.75	55.27	50.83
PEG	-35.32	1.49	-2.30
Price/Book	-26.44	6.39	8.69
Price/Cash Flow	-50.35	58.78	118.39
Prices/Earnings	-34.78	22.95	35.19
Price/Sales	-27.81	10.77	14.92
Price/FCF	-50.35	58.78	118.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	8.23	0.33	0.31
Operating Margin	20.38	0.17	0.14
ROA	9.33	0.04	0.03
ROE	0.06	0.07	12.78
ROIC	0.06	0.07	6.76
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.46	0.03	1695.79
Dividends QOQ	< 0.005	< 0.005	28.68
EBIT QOQ	-0.20	0.25	28.05
EPS QOQ	-0.15	0.15	0.83
FCF QOQ	3.63	0.52	-85.82
Revenue QOQ	-0.03	0.04	61.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	0.00	inf
Days Sales Outstanding (DSO)	74.51	72.14	-3.18
Inventory Turnover	10916199000.00	0.00	inf
Debt/Capitalization	0.03	0.08	153.50
Quick Ratio	1.13	1.03	-8.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	43.12	44.15	2.40
Cash	8.15	8.82	8.24
Capex	-0.17	-0.20	-13.13
Free Cash Flow	3.17	4.80	51.72
Revenue	25.12	26.21	4.33
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.26	1.16	-8.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.73	-0.29	60.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating